IG
JAZZ icon

ING Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

ING Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.95M Sell
12,244
-15,970
-57% -$3.5M 0.01% 366
2026
Q1 		$5.33M Sell
28,214
-23,986
-46% -$4.19M 0.03% 265
2025
Q4 		$8.87M Buy
+52,200
New +$8M 0.05% 214

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

ING Group's JAZZ Position: Q2 2026 in Review

ING Group reduced its Jazz Pharmaceuticals (JAZZ) stake by 57% in Q2 2026, selling an estimated $3.5M and leaving 12,244 shares worth $2.95M. The position accounts for 0.01% of the portfolio, ranked #366.

ING Group first reported a position in JAZZ in Q4 2025 and has held it in 3 quarters since. The position peaked at $8.87M in Q4 2025. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • ING Group held 12,244 shares of Jazz Pharmaceuticals worth $2.95M as of Q2 2026.
  • ING Group sold 15,970 Jazz Pharmaceuticals shares in Q2 2026, an estimated $3.5M.
  • Jazz Pharmaceuticals made up 0.01% of ING Group's portfolio in Q2 2026, its #366 holding.
  • ING Group first reported a position in Jazz Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • ING Group's Jazz Pharmaceuticals position peaked at $8.87M in Q4 2025.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on ING Group's 13F filing for Q2 2026, filed 13 Aug 2026.